Phencyclidine-like discriminative effects of opioids in the rat.
S. Holtzman
Journal of Pharmacology and Experimental Therapeutics September 1, 1980 DOI: 10.1016/s0022-3565(25)32225-1 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Animal discrimination study Peer reviewed |
|---|---|
| Population | Rats |
| Interventions | Phencyclidine Ketamine Cyclazocine SKF 10 047 Dextrorphan Ethylketocyclazocine Ketocyclazocine Pentazocine Dextromethorphan Naltrexone |
| Dose | 2.0 mg/kg PCP; naltrexone 1.0 mg/kg |
| Key points | Ketamine and the opioids cyclazocine, SKF 10,047, and dextrorphan produced PCP-like discriminative stimulus effects in rats trained to discriminate 2.0 mg/kg PCP from saline, whereas ethylketocyclazocine, ketocyclazocine, pentazocine, and dextromethorphan did not. Naltrexone did not block cyclazocine's PCP-like effects, which the authors interpret as evidence that PCP and certain opioids share a common, non-opioid-receptor-mediated component of action. |
Abstract
Possible commonalities in the discriminative stimulus properties of phencyclidine (PCP) and opioids were investigated in rats trained to discriminate between i.p. injections of saline and 2.0 mg/kg of PCP in a two-choice discrete-trial avoidance paradigm. Behavior was considered to be under stimulus control when a rat reliably completed at least 18 trials of a 20-trial session on the appropriate choice lever after receiving PCP or saline. Tests of stimulus generalization were performed over an 8- to 32-fold range of doses with ketamine, a PCP analog, and eight opioids. Dose- and time-dependent stimulus control of behavior comparable to that produced by 2.0 mg/kg of PCP (defined by the number of trials completed on the PCP-appropriate choice lever) were produced by ketamine and the opioids cyclazocine, SKF 10,047 and dextrorphan. These drugs also produced orderly increases in responses during the interval between trials suggestive of a relationship between this effect and PCP-like stimulus control. In contrast, after ethylketocyclazocine, ketocyclazocine, pentazocine and dextromethorphan trials were completed primarily on the saline-appropriate lever and responding between trials produced did not change. Neither the PCP-like stimulus control of behavior nor the increased responding between trials produced by cyclazocine were prevented by pretreatment with naltrexone (1.0 mg/kg). These results provide further evidence that PCP and certain opioids share a common component of action that is probably mediated by neuronal substrates not usually associated with the activity of opioids.
Citations in the library
Cited by 15
- Some distorted thoughts about ketamine as a psychedelic and a novel hypothesis based on NMDA receptor-mediated synaptic plasticity. Neuropharmacology November 2018
- Ketamine and phencyclidine: the good, the bad and the unexpected. British Journal of Pharmacology September 2015
- Self-administration of delta9-tetrahydrocannabinol (THC) by drug naive squirrel monkeys. Psychopharmacology September 2003
- Dizocilpine-like discriminative stimulus effects of low-affinity uncompetitive NMDA antagonists. Neuropharmacology 1996
- Discriminative stimulus effects of dextromethorphan in the rat. Psychopharmacology November 1994
and 10 more in the library